TEAD4 and gastric adenocarcinoma: By using the GEPIA dataset, we further compared the expression of TEADs in stomach adenocarcinoma with normal samples, and consistent with Cho’s results, the expression level of TEAD4 was about 2 folds in tumor than normal samples (Fig. 1B).